Vaccination News Home Page

http://jama.ama-assn.org/issues/current/ffull/jlt0925-3.html


LoginJournals of AMA HomeFeedbackSite Map

SubscribeRegisterSearchDocument DeliveryE-Mail AlertClassified
How to use this site
Previous Vol. 288 No. 12,
September 25, 2002

Next
JAMACurrent IssueIndexesPast Issue Index
Letters


 


 

Printable version of this item

See Related:
Authors' Articles
 

Return to
Table of Contents


 

Methods

Results

Comment

Letters Information

INDEX OF FIGURES AND TABLES


to bottom
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
to TOP

 

Methods

Results

Comment

Letters Information

INDEX OF FIGURES AND TABLES


to bottom
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
to TOP

 

Methods

Results

Comment

Letters Information

INDEX OF FIGURES AND TABLES


to bottom
 


 
RESEARCH LETTER  
 
Effect of Sleep Deprivation on Response to Immunizaton  
 
 

To the Editor: Popular wisdom holds that not getting enough sleep increases the propensity of catching a cold or other ailments. In America, sleep duration has steadily declined from nearly 9 hours in 1960 to less than 7 hours currently.1, 2 Although adverse effects of sleep deprivation on immune parameters have been documented,3 the clinical implications of these findings are unclear. We examined the effect of sleep deprivation on immune response to influenza vaccination.


 
 

Methods


 

Subjects were 25 healthy young men (mean age, 23 years) who consented to participate in a protocol approved by our institutional review board. Eligibility criteria included bedtime between 11 PM and 1 AM, waking time between 7 and 9 AM, and time in bed of 7.5 to 8.5 hours. None of the subjects had been immunized against influenza during the preceding 3 years. Eleven subjects had their bedtime restricted to 4 hours (1-5 AM) for 6 nights and then extended to 12 hours per night for 7 nights to recover from sleep loss.4 Between 9:00 and 10:00 on the morning following the fourth short night, they were immunized against influenza (0.5-mL intramuscular injection, Influenza Virus Vaccine, Trivalent Types A and B, Fluogen, 1996-1997 influenza season, Parke-Davis, Morris Plains, NJ). A second group of 14 subjects served as controls and maintained their usual bedtimes prior to receiving the same vaccine under the same conditions. The 2 groups were recruited from the same pool of subjects, fulfilled the same inclusion criteria, and did not differ in terms of age, body mass index, and ethnic background. All subjects were seropositive for anti-influenza IgG antibody at baseline and mean titers were similar in both groups.

To assess anti-influenza IgG antibody titers throughout the major phases of the antibody response, a morning blood sample was taken immediately before vaccination (baseline), as well as 10 days (during the log phase, when antibody titer increases logarithmically) and 21 to 30 days (during the plateau phase, when antibody titer stabilizes) after vaccination. Antibody titers were measured in all samples using an enzyme-linked immunosorbent assay, with the vaccine used to immunize the subjects as the antigen.5


 
 

Results


 

Ten days after vaccination, mean (SD) antibody titers in subjects who were immunized in a state of sleep debt were less than half those measured in the subjects with normal sleep times (0.50 106 [0.46 106] vs 1.15 106 [1.00 106], respectively; P = .03 by Mann-Whitney test; Figure 1). At 3 to 4 weeks after vaccination, antibody titers were no longer significantly different. Repeated-measures analysis of variance of natural log-transformed antibody titers with sleep condition as a factor revealed a significant (P = .04) effect of sleep duration on antibody titers.


 
 

Comment


 

Sleep deprivation at the time of vaccination reduced the response during the log phase of antibody production despite a prolonged period of sleep recovery after vaccination. These results suggest that the response to influenza vaccination may be impaired in individuals with chronic partial sleep restriction. Because adults who show poorer responses to vaccines and other antigenic challenges also experience higher rates of clinical illness,6 our findings support the concept that adequate amounts of sleep are needed for optimal resistance to infectious challenge.


 
Karine Spiegel, PhD
Department of Medicine
University of Chicago
Chicago, Ill

John F. Sheridan, PhD
Departments of Oral Biology and Molecular Virology and Immunology
the Ohio State University
Columbus

Eve Van Cauter, PhD
Department of Medicine
University of Chicago
 
 

1. Kripke DF, Simons R, Garfinkel L, Hammond E. Short and long sleep and sleeping pills: is increased mortality associated? Arch Gen Psychiatry. 1979;36:103-116. MEDLINE

2. National Sleep Foundation (NSF). 2000 Omnibus Sleep in America Poll. Washington, DC: NSF; 2000. Available at: http://www.sleepfoundation.org/publications/2000poll.html. Accessibility verified August 13, 2002.

3. Krueger JM, Fang J, Floyd RA. Relationship between sleep and immune function. In: Turek FW, Zee PC, eds. Regulation of Sleep and Circadian Rhythms. New York, NY: Marcel Dekker Inc; 1999:427-464.

4. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-1439. MEDLINE

5. Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A. 1996;93:3043-3047. MEDLINE

6. McGlone FB, Arden NH. Impact of influenza in geriatrics and action plan for prevention and treatment. Am J Med. 1987;82(suppl A):55-57. MEDLINE
 
 

Funding/Support: This work was supported by a grant from the Mind-Body Network of the MacArthur Foundation (Chicago, Ill), and by National Institutes of Health grants DK-41814 and AG-11412. The General Clinical Research Center of the University of Chicago is supported by National Institutes of Health grant M01-RR00055. The vaccine was provided by Parke-Davis, Morris Plains, NJ.

Acknowledgment: We thank the study participants for their cooperation and Egidio Colecchia for assistance with data acquisition.

 
JOC80004
 
Letters Information  
 
Guidelines for Letters
 
 
Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
 
 
 


 


 
 
to Top
 
 

 

 
© 2002 American Medical Association. All rights reserved.
 
 
AMA HomeJAMA Info Centers Home Short Cut

Go

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.